BPTHOTCPharmaceutical PreparationsFiscal year ends December 31
BIO-PATH HOLDINGS, INC.
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on May 20, 2026
$0.00+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $2.80K
- P/E (TTM)
- –
- Dividend yield
- –
Bio-Path statistics
Financials through Mar 31, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Bio-Path | Industry median |
|---|---|---|
| Market Cap | $15.09K | $197.05M |
| Enterprise Value | $3.09K | $106.56M |
Balance sheet
| Measure | Bio-Path | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $12.00K | $62.42M |
| Net Cash (Debt) | $12.00K | $15.68M |
| Net Cash Per Share | $0.00 | $0.65 |
| Equity (Book Value) | -$8.49M | $48.79M |
| Book Value Per Share | -$0.17 | $1.36 |
| Tangible Book Value | -$8.49M | $23.06M |
| Working Capital | -$8.47M | $75.77M |
Financial position
| Measure | Bio-Path | Industry median |
|---|---|---|
| Current Ratio | 0.07 | 3.30 |
| Quick Ratio | 0.00 | 2.39 |
Efficiency
| Measure | Bio-Path | Industry median |
|---|---|---|
| Employee Count | 10 | 73 |
Shares
| Measure | Bio-Path | Industry median |
|---|---|---|
| Shares Outstanding | 50,297,500 | 59,128,900 |
| Shares Change (QoQ) | 62.0% | 0.54% |
| Float | 50,297,500 | 48,744,500 |
| Shares Held by Insiders | 0.00% | 11.8% |
Scores
| Measure | Bio-Path | Industry median |
|---|---|---|
| Altman Z-Score | -276.50 | 0.10 |
Calculated by StockData from Bio-Path's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.